Hepatic steatosis and Vaginal discharge
Vaginal discharge is reported only by a few people with Hepatic steatosis.
The study analyzes which people have Vaginal discharge with Hepatic steatosis. It is created by eHealthMe based on 2 people who have Vaginal discharge and Hepatic steatosis from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who have Hepatic Steatosis and Vaginal Discharge are studied.
What is Hepatic steatosis?
Hepatic steatosis (fatty liver disease) is found to be associated with 1,923 drugs and 1,315 conditions by eHealthMe.
What is Vaginal discharge?
Vaginal discharge is found to be associated with 1,584 drugs and 1,074 conditions by eHealthMe.
Number of Vaginal discharge in Hepatic steatosis reports submitted per year:
Gender of people who have Hepatic Steatosis and experienced Vaginal Discharge *:
- female: 100 %
- male: 0.0 %
Age of people who have Hepatic Steatosis and experienced Vaginal Discharge *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 100 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 50.00%
- Pain: 1 person, 50.00%
- Neuralgia (pain in one or more nerves): 1 person, 50.00%
- Depression: 1 person, 50.00%
- Birth Control: 1 person, 50.00%
Common drugs taken by these people *:
- Valtrex: 1 person, 50.00%
- Ocrevus: 1 person, 50.00%
- Metformin: 1 person, 50.00%
- Lamictal: 1 person, 50.00%
- Invokana: 1 person, 50.00%
- Elavil: 1 person, 50.00%
- Crestor: 1 person, 50.00%
- Ativan: 1 person, 50.00%
- Aldactone: 1 person, 50.00%
Common symptoms for these people *:
- Vulvovaginal Dryness: 1 person, 50.00%
- Morose (sullen and ill-tempered): 1 person, 50.00%
- Back Pain: 1 person, 50.00%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 50.00%
- Cough: 1 person, 50.00%
- Depressed Mood: 1 person, 50.00%
- Fatigue (feeling of tiredness): 1 person, 50.00%
- Feeling Hot: 1 person, 50.00%
- Haemorrhage (bleeding): 1 person, 50.00%
- Heavy Or Prolong Menstrual Bleeding: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Vaginal discharge?Check whether Vaginal discharge is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Vaginal discharge:
- Vaginal discharge in Moderna COVID Vaccine
- Vaginal discharge in Pfizer BioNTech Covid Vaccine
- Vaginal discharge in Johnson and Johnson Covid Vaccine
Common drugs associated with Vaginal discharge:
All the drugs that are associated with Vaginal discharge:
- Vaginal discharge (1,584 drugs)
Common conditions associated with Vaginal discharge:
All the conditions that are associated with Vaginal discharge:
- Vaginal discharge (1,074 conditions)
How the study uses the data?
The study is based on Vaginal discharge and Hepatic steatosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Maxidex and Corneal Lesion - now
- Ofloxacin and Difficulty In Walking - 2 seconds ago
- Remodulin and Cardiopulmonary Failure - 12 seconds ago
- Drug Withdrawal Headache and drugs of ingredients of cetirizine hydrochloride - 13 seconds ago
- Crestor and Postoperative Wound Infection - 17 seconds ago
- Prozac and Dry Throat - 18 seconds ago
- Jadenu and Drowsiness - 26 seconds ago
- Divalproex Sodium and Renal Failure Chronic - 26 seconds ago
- Selenium and Splenomegaly - 26 seconds ago
- Cefazolin and Cardiac Valve Replacement Complication - 27 seconds ago